Stéphanie Beq, PhD

Dr Stéphanie Beq is R&D director at Thabor Therapeutics, a biotechnology company developing innovative treatments for human mucosal inflammatory diseases. Stéphanie spent 15 years in research and drug discovery & development in immunology. 

Stéphanie holds a PhD in immunological studies from the laboratory of Françoise Barre-Sinoussi (Nobel Prize in 2008).